A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease

BACKGROUND AND PURPOSE: Acetyl-L-carnitine (ALC) is a widely used drug for various neurodegenerative diseases including dementia. The aim of the present study was to elucidate the efficacy of ALC in dementia patients with cerebrovascular disease (vascular cognitive impairment; VCI). METHODS: Fifty-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, YoungSoon, Choi, Hojin, Lee, Chan-Nyoung, Kim, Yong Bum, Kwak, Yong Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dementia Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427993/
https://www.ncbi.nlm.nih.gov/pubmed/30906386
http://dx.doi.org/10.12779/dnd.2018.17.1.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427993/
https://www.ncbi.nlm.nih.gov/pubmed/30906386
http://dx.doi.org/10.12779/dnd.2018.17.1.1

Ejemplares similares